BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bradlow WM, Hughes ML, Keenan NG, Bucciarelli-Ducci C, Assomull R, Gibbs JS, Mohiaddin RH. Measuring the heart in pulmonary arterial hypertension (PAH): implications for trial study size. J Magn Reson Imaging 2010;31:117-24. [PMID: 20027579 DOI: 10.1002/jmri.22011] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
Number Citing Articles
1 van Campen JS, de Boer K, van de Veerdonk MC, van der Bruggen CE, Allaart CP, Raijmakers PG, Heymans MW, Marcus JT, Harms HJ, Handoko ML, de Man FS, Vonk Noordegraaf A, Bogaard HJ. Bisoprolol in idiopathic pulmonary arterial hypertension: an explorative study. Eur Respir J 2016;48:787-96. [PMID: 27390285 DOI: 10.1183/13993003.00090-2016] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 9.2] [Reference Citation Analysis]
2 Göransson C, Vejlstrup N, Carlsen J. Reproducibility of peak filling and peak emptying rate determined by cardiovascular magnetic resonance imaging for assessment of biventricular systolic and diastolic dysfunction in patients with pulmonary arterial hypertension. Int J Cardiovasc Imaging 2018;34:777-86. [PMID: 29168055 DOI: 10.1007/s10554-017-1281-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
3 van de Veerdonk MC, Kind T, Marcus JT, Mauritz G, Heymans MW, Bogaard H, Boonstra A, Marques KM, Westerhof N, Vonk-noordegraaf A. Progressive Right Ventricular Dysfunction in Patients With Pulmonary Arterial Hypertension Responding to Therapy. Journal of the American College of Cardiology 2011;58:2511-9. [DOI: 10.1016/j.jacc.2011.06.068] [Cited by in Crossref: 514] [Cited by in F6Publishing: 427] [Article Influence: 46.7] [Reference Citation Analysis]
4 Spruijt OA, Di Pasqua MC, Bogaard HJ, van der Bruggen CE, Oosterveer F, Marcus JT, Vonk-Noordegraaf A, Handoko ML. Serial assessment of right ventricular systolic function in patients with precapillary pulmonary hypertension using simple echocardiographic parameters: A comparison with cardiac magnetic resonance imaging. J Cardiol 2017;69:182-8. [PMID: 27012754 DOI: 10.1016/j.jjcc.2016.02.019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
5 Venner C, Odille F, Voilliot D, Chaouat A, Chabot F, Felblinger J, Bonnemains L. Can MRI detect pulmonary hypertension in a population pre-selected by echocardiography? Acta Radiol 2018;59:180-7. [PMID: 28595488 DOI: 10.1177/0284185117712541] [Reference Citation Analysis]
6 Swift AJ, Rajaram S, Capener D, Elliot C, Condliffe R, Wild JM, Kiely DG. LGE Patterns in Pulmonary Hypertension Do Not Impact Overall Mortality. JACC: Cardiovascular Imaging 2014;7:1209-17. [DOI: 10.1016/j.jcmg.2014.08.014] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 6.6] [Reference Citation Analysis]
7 Asano R, Ogo T, Morita Y, Kotoku A, Aoki T, Hirakawa K, Nakayama S, Ueda J, Tsuji A, Waddingham MT, Ohta Y, Fukuda T, Ohta-Ogo K, Ishibashi-Ueda H, Noguchi T, Yasuda S. Prognostic value of right ventricular native T1 mapping in pulmonary arterial hypertension. PLoS One 2021;16:e0260456. [PMID: 34843578 DOI: 10.1371/journal.pone.0260456] [Reference Citation Analysis]
8 Trip P, Kind T, van de Veerdonk MC, Marcus JT, de Man FS, Westerhof N, Vonk-noordegraaf A. Accurate assessment of load-independent right ventricular systolic function in patients with pulmonary hypertension. The Journal of Heart and Lung Transplantation 2013;32:50-5. [DOI: 10.1016/j.healun.2012.09.022] [Cited by in Crossref: 79] [Cited by in F6Publishing: 69] [Article Influence: 8.8] [Reference Citation Analysis]
9 Brewis MJ, Bellofiore A, Vanderpool RR, Chesler NC, Johnson MK, Naeije R, Peacock AJ. Imaging right ventricular function to predict outcome in pulmonary arterial hypertension. Int J Cardiol 2016;218:206-11. [PMID: 27236116 DOI: 10.1016/j.ijcard.2016.05.015] [Cited by in Crossref: 60] [Cited by in F6Publishing: 50] [Article Influence: 10.0] [Reference Citation Analysis]
10 Weir-McCall JR, Liu-Shiu-Cheong PS, Struthers AD, Lipworth BJ, Houston JG. Pulmonary arterial stiffening in COPD and its implications for right ventricular remodelling. Eur Radiol 2018;28:3464-72. [PMID: 29488084 DOI: 10.1007/s00330-018-5346-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
11 Lahm T, Douglas IS, Archer SL, Bogaard HJ, Chesler NC, Haddad F, Hemnes AR, Kawut SM, Kline JA, Kolb TM, Mathai SC, Mercier O, Michelakis ED, Naeije R, Tuder RM, Ventetuolo CE, Vieillard-Baron A, Voelkel NF, Vonk-Noordegraaf A, Hassoun PM; American Thoracic Society Assembly on Pulmonary Circulation. Assessment of Right Ventricular Function in the Research Setting: Knowledge Gaps and Pathways Forward. An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med 2018;198:e15-43. [PMID: 30109950 DOI: 10.1164/rccm.201806-1160ST] [Cited by in Crossref: 95] [Cited by in F6Publishing: 48] [Article Influence: 31.7] [Reference Citation Analysis]
12 Bradlow WM, Gibbs JS, Mohiaddin RH. Cardiovascular magnetic resonance in pulmonary hypertension. J Cardiovasc Magn Reson 2012;14:6. [PMID: 22257586 DOI: 10.1186/1532-429X-14-6] [Cited by in Crossref: 46] [Cited by in F6Publishing: 20] [Article Influence: 4.6] [Reference Citation Analysis]
13 Lu JC, Christensen JT, Yu S, Donohue JE, Ghadimi Mahani M, Agarwal PP, Dorfman AL. Relation of right ventricular mass and volume to functional health status in repaired tetralogy of Fallot. Am J Cardiol 2014;114:1896-901. [PMID: 25438919 DOI: 10.1016/j.amjcard.2014.09.027] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
14 Kazimierczyk R, Malek LA, Szumowski P, Nekolla SG, Blaszczak P, Jurgilewicz D, Hladunski M, Sobkowicz B, Mysliwiec J, Grzywna R, Musial WJ, Kaminski KA. Multimodal assessment of right ventricle overload-metabolic and clinical consequences in pulmonary arterial hypertension. J Cardiovasc Magn Reson 2021;23:49. [PMID: 33966635 DOI: 10.1186/s12968-021-00743-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Wong YY, Westerhof N, Ruiter G, Lubberink M, Raijmakers P, Knaapen P, Marcus JT, Boonstra A, Lammertsma AA, van der Laarse WJ, Vonk-noordegraaf A. Systolic pulmonary artery pressure and heart rate are main determinants of oxygen consumption in the right ventricular myocardium of patients with idiopathic pulmonary arterial hypertension. European Journal of Heart Failure 2011;13:1290-5. [DOI: 10.1093/eurjhf/hfr140] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
16 Göransson C, Vejlstrup N, Scheike T, Carlsen J. Implications of cardiac variability with cardiovascular magnetic resonance imaging for calculating trial sample size in pulmonary arterial hypertension. International Journal of Cardiology 2018;257:332-8. [DOI: 10.1016/j.ijcard.2017.11.020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
17 Li Y, Wang Y, Zhai Z, Guo X, Yang Y, Lu X. Real-Time Three-Dimensional Echocardiography to Assess Right Ventricle Function in Patients with Pulmonary Hypertension. PLoS One. 2015;10:e0129557. [PMID: 26075788 DOI: 10.1371/journal.pone.0129557] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
18 Goo HW. Right Ventricular Mass Quantification Using Cardiac CT and a Semiautomatic Three-Dimensional Hybrid Segmentation Approach: A Pilot Study. Korean J Radiol 2021;22:901-11. [PMID: 33660457 DOI: 10.3348/kjr.2020.0787] [Reference Citation Analysis]
19 Freed BH, Gomberg-Maitland M, Chandra S, Mor-Avi V, Rich S, Archer SL, Jamison EB Jr, Lang RM, Patel AR. Late gadolinium enhancement cardiovascular magnetic resonance predicts clinical worsening in patients with pulmonary hypertension. J Cardiovasc Magn Reson 2012;14:11. [PMID: 22296860 DOI: 10.1186/1532-429X-14-11] [Cited by in Crossref: 133] [Cited by in F6Publishing: 54] [Article Influence: 13.3] [Reference Citation Analysis]
20 Li YD, Wang YD, Zhai ZG, Guo XJ, Wu YF, Yang YH, Lu XZ. Relationship between echocardiographic and cardiac magnetic resonance imaging-derived measures of right ventricular function in patients with chronic thromboembolic pulmonary hypertension. Thromb Res 2015;135:602-6. [PMID: 25628143 DOI: 10.1016/j.thromres.2015.01.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
21 Liu-Shiu-Cheong PSK, Lipworth BJ, Weir-McCall JR, Houston JG, Struthers AD. Allopurinol in Patients with Pulmonary Hypertension Associated with Chronic Lung Disease. Int J Chron Obstruct Pulmon Dis 2020;15:2015-24. [PMID: 32904701 DOI: 10.2147/COPD.S260917] [Reference Citation Analysis]
22 van de Veerdonk MC, Dusoswa SA, Marcus JT, Bogaard HJ, Spruijt O, Kind T, Westerhof N, Vonk-Noordegraaf A. The importance of trabecular hypertrophy in right ventricular adaptation to chronic pressure overload. Int J Cardiovasc Imaging 2014;30:357-65. [PMID: 24306052 DOI: 10.1007/s10554-013-0338-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
23 Kazimierczyk R, Małek ŁA, Szumowski P, Błaszczak P, Jurgilewicz D, Hładuński M, Sobkowicz B, Myśliwiec J, Grzywna R, Musiał WJ, Kamiński KA. Prognostic value of late gadolinium enhancement mass index in patients with pulmonary arterial hypertension. Adv Med Sci 2021;66:28-34. [PMID: 33249368 DOI: 10.1016/j.advms.2020.11.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
24 Swift AJ, Rajaram S, Condliffe R, Capener D, Hurdman J, Elliot CA, Wild JM, Kiely DG. Diagnostic accuracy of cardiovascular magnetic resonance imaging of right ventricular morphology and function in the assessment of suspected pulmonary hypertension results from the ASPIRE registry. J Cardiovasc Magn Reson 2012;14:40. [PMID: 22720870 DOI: 10.1186/1532-429X-14-40] [Cited by in Crossref: 79] [Cited by in F6Publishing: 30] [Article Influence: 7.9] [Reference Citation Analysis]
25 Ventetuolo CE, Mitra N, Wan F, Manichaikul A, Barr RG, Johnson C, Bluemke DA, Lima JA, Tandri H, Ouyang P, Kawut SM. Oestradiol metabolism and androgen receptor genotypes are associated with right ventricular function. Eur Respir J 2016;47:553-63. [PMID: 26647441 DOI: 10.1183/13993003.01083-2015] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 5.3] [Reference Citation Analysis]
26 Lewandowski AJ, Bradlow WM, Augustine D, Davis EF, Francis J, Singhal A, Lucas A, Neubauer S, McCormick K, Leeson P. Right ventricular systolic dysfunction in young adults born preterm. Circulation. 2013;128:713-720. [PMID: 23940387 DOI: 10.1161/circulationaha.113.002583] [Cited by in Crossref: 147] [Cited by in F6Publishing: 79] [Article Influence: 16.3] [Reference Citation Analysis]
27 Freed BH, Patel AR, Lang RM. Redefining the Role of Cardiovascular Imaging in Patients with Pulmonary Arterial Hypertension. Curr Cardiol Rep 2012;14:366-73. [DOI: 10.1007/s11886-012-0253-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
28 Broncano J, Bhalla S, Gutierrez FR, Vargas D, Williamson EE, Makan M, Luna A. Cardiac MRI in Pulmonary Hypertension: From Magnet to Bedside. Radiographics 2020;40:982-1002. [PMID: 32609599 DOI: 10.1148/rg.2020190179] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
29 Mathai SC. Precision medicine in pulmonary hypertension: Start with the end (point). Int J Cardiol 2018;257:339-40. [PMID: 29506725 DOI: 10.1016/j.ijcard.2018.01.033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
30 Hassoun PM, Zamanian RT, Damico R, Lechtzin N, Khair R, Kolb TM, Tedford RJ, Hulme OL, Housten T, Pisanello C, Sato T, Pullins EH, Corona-Villalobos CP, Zimmerman SL, Gashouta MA, Minai OA, Torres F, Girgis RE, Chin K, Mathai SC. Ambrisentan and Tadalafil Up-front Combination Therapy in Scleroderma-associated Pulmonary Arterial Hypertension. Am J Respir Crit Care Med 2015;192:1102-10. [PMID: 26360334 DOI: 10.1164/rccm.201507-1398OC] [Cited by in Crossref: 92] [Cited by in F6Publishing: 44] [Article Influence: 15.3] [Reference Citation Analysis]
31 van Echteld CJA, Beckmann N. A View on Imaging in Drug Research and Development for Respiratory Diseases. J Pharmacol Exp Ther 2011;337:335-49. [DOI: 10.1124/jpet.110.172635] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
32 Addetia K, Bhave NM, Tabit CE, Gomberg-Maitland M, Freed BH, Dill KE, Lang RM, Mor-Avi V, Patel AR. Sample size and cost analysis for pulmonary arterial hypertension drug trials using various imaging modalities to assess right ventricular size and function end points. Circ Cardiovasc Imaging 2014;7:115-24. [PMID: 24192452 DOI: 10.1161/CIRCIMAGING.113.000932] [Cited by in Crossref: 27] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
33 Chia KS, Faux SG, Wong PK, Holloway C, Assareh H, McLachlan CS, Kotlyar E. Randomised controlled trial examining the effect of an outpatient exercise training programme on haemodynamics and cardiac MR parameters of right ventricular function in patients with pulmonary arterial hypertension: the ExPAH study protocol. BMJ Open 2017;7:e014037. [PMID: 28167746 DOI: 10.1136/bmjopen-2016-014037] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
34 Bradlow WM, Babu-narayan SV, Mohiaddin RH. Pulmonary Hypertension in Congenital Heart Disease. In: Saremi F, editor. Cardiac CT and MR for Adult Congenital Heart Disease. New York: Springer; 2014. pp. 553-72. [DOI: 10.1007/978-1-4614-8875-0_25] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
35 Swift AJ, Rajaram S, Hurdman J, Hill C, Davies C, Sproson TW, Morton AC, Capener D, Elliot C, Condliffe R, Wild JM, Kiely DG. Noninvasive Estimation of PA Pressure, Flow, and Resistance With CMR Imaging. JACC: Cardiovascular Imaging 2013;6:1036-47. [DOI: 10.1016/j.jcmg.2013.01.013] [Cited by in Crossref: 96] [Cited by in F6Publishing: 83] [Article Influence: 10.7] [Reference Citation Analysis]
36 Yang T, Liang Y, Zhang Y, Gu Q, Chen G, Ni XH, Lv XZ, Liu ZH, Xiong CM, He JG. Echocardiographic parameters in patients with pulmonary arterial hypertension: correlations with right ventricular ejection fraction derived from cardiac magnetic resonance and hemodynamics. PLoS One 2013;8:e71276. [PMID: 23967181 DOI: 10.1371/journal.pone.0071276] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
37 Swift AJ, Wild JM, Nagle SK, Roldán-Alzate A, François CJ, Fain S, Johnson K, Capener D, van Beek EJ, Kiely DG, Wang K, Schiebler ML. Quantitative magnetic resonance imaging of pulmonary hypertension: a practical approach to the current state of the art. J Thorac Imaging 2014;29:68-79. [PMID: 24552882 DOI: 10.1097/RTI.0000000000000079] [Cited by in Crossref: 46] [Cited by in F6Publishing: 14] [Article Influence: 5.8] [Reference Citation Analysis]